Aetna sells Part D plans to WellCare in a 'significant step' toward closing CVS deal

handshake over a desk with computers and someone taking notes
WellCare will absorb Aetna's 2.2 million Part D members once the CVS deal is finalized. (rawpixel)

WellCare Health Plans has agreed to purchase Aetna's entire standalone Part D business, a move that is likely to help the insurer win over regulators in its merger with CVS.

Aetna's Part D plans include 2.2 million members. Aetna will retain the financial risks and continue providing administrative services for the plans through 2019, according to a financial filing from WellCare. The purchase is subject to the closing of the $69 billion CVS-Aetna merger, which is expected to close by the end of the year.

The terms of the deal were not disclosed by either company, but Aetna's SEC filing stated the "purchase price is not material to Aetna." WellCare said it will fund the purchase with cash on hand.

eBook

9 Tips for Implementing the Best Mobile App Strategy

The member mobile app is a powerful tool for payers and members. It can help improve health outcomes, reduce operational costs, and drive self-service — anytime, anywhere. In this new eBook, learn tips and tricks to implementing the best mobile app strategy now.

RELATED: DOJ nearing approval of CVS-Aetna, Cigna-Express Scripts mergers

WellCare was rumored to be a player in Aetna's Part D divestiture designed to appease antitrust regulators by limiting the consolidation of Part D plans in its merger with CVS. Both the California Health Insurance Commissioner and the American Medical Association have raised concerns about a lack of Part D competition as a result of the deal. 

"CVS Health believes the divestiture is a significant step toward completing the DOJ’s review of the CVS Health transaction," CVS said in a separate filing. "CVS Health and Aetna continue to engage in productive discussions with the DOJ. CVS Health continues to expect the CVS Health Transaction to close in the early part of the fourth quarter of 2018."

WellCare just recently completed a $2.5 billion acquisition of Meridian Health, adding a pharmacy benefit manager to its portfolio.

Suggested Articles

CMS announced it will offer the COVID-19 vaccine to Medicare beneficiaries at no cost to patients and issued new add-on payments for virus treatments.

HHS will give out $333 million in incentive payments to nursing homes who lowered their COVID-19 case and death counts in September.

Nearly half of employees have deferred care amid the pandemic, according to a new survey from Willis Towers Watson.